Small Animal Studies
There are currently no calls for Small Companion Animal (Dog and Cat) proposals on the traditional application cycle (Established Investigator, First Award, Fellowship Training and Pilot Study). Scroll down for other funding opportunities.
Proposals on topics relevant to small companion animal health and welfare were due on March 16, 2016. Funding decisions will be made in early July 2016 with grant awards starting as early as August 1, 2016.
The next call for small companion animal health and welfare proposals will be in late December 2016 with proposals due on March 15, 2017.
For more information or for questions, click here
Proactive Research Calls
Morris Animal Foundation is now accepting proposals for the next phase of the Osteosarcoma Project. The Osteosarcoma Project provides a framework for conception, design and execution of clinical trials of novel agents in pet dogs with osteosarcoma (OSA) to expressly define the impact of drug exposure on tumor metastasis, which is the leading cause of death in canine and human osteosarcoma patients.
The goal of the project is to have a series of investigational agents evaluated in dogs with appendicular osteosarcoma under a 5-year effort through the Comparative Oncology Trials Consortium (COTC). The Comparative Oncology Trials Consortium (COTC) is an active network of twenty-two academic comparative oncology centers, centrally managed by the NIH-NCI-Center for Cancer Research's Comparative Oncology Program. An initial arm of this effort involved the accrual of dogs receiving Standard of Care (SOC) therapy in order to discern the impact of investigational agents given in the adjuvant setting in addition to SOC.
For this project SOC is defined as amputation of the affected limb, followed by 4 doses of intravenous carboplatin chemotherapy given on a q21 day schedule. Cases will be prospectively and randomly enrolled at a number of COTC sites in an effort to minimize bias and eliminate disadvantages of historical control data. The ratio of dogs in the control arm: dogs in each investigational arm will be 1:1. Each investigational arm will contain 80 dogs prospectively enrolled over a 12-24-month period. The SOC arm and the first investigational arm opened in November of 2015. The first investigational agent selected was Rapamycin. Accrual is expected to be complete for both studies by December 2016.
We are now seeking proposals for additional investigational agents to be evaluated against the SOC arm currently in progress. The successful applicant will work with the NCI-COTC to develop a full clinical protocol in line with the budgetary guidelines and allowable costs for clinical management of dogs enrolled to the protocol.
Proposals are due Monday, August 1, 2016, by 11:59 p.m. EST.
Click here for the Request For Proposals (RFP)
Click here for the Proposal Guidelines
Click here for the Online Application Instructions (includes a link to the online form)
For more information or if you have specific questions, please email Christina Mazcko, email@example.com.
REQUEST FOR PROPOSALS:
Human Animal Bond Research Initiative (HABRI) Foundation
Addressing Evidence-based Health Benefits of Human-Animal Interaction
Proposals on topics relevant to HABRI were due on January 27, 2016. Funding decisions will be made in May 2016 and grant awards may start as early as July 1, 2016.